Results 161 to 170 of about 161,793 (289)

The curious incident of TdT-mediated mutations in AML [PDF]

, 2019
George S. Vassiliou
openalex   +1 more source

Supplemental Figure 2 from T-Cell Immunoglobulin and ITIM Domain (TIGIT) Associates with CD8⁺ T-Cell Exhaustion and Poor Clinical Outcome in AML Patients

, 2023
Yaxian Kong, Liuluan Zhu, Todd D. Schell, Jianhong Zhang, David F. Claxton, W. Christopher Ehmann, Witold B. Rybka, Melissa George, Hui Zeng, Hong Zheng   +9 more
openalex   +1 more source

The Evolution of Pneumocystis jirovecii Pneumonia Prophylaxis for Pediatric Patients With Extracranial Solid Tumors: A Review of Historical Insights and Future Directions

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Pneumocystis jirovecii pneumonia (PJP) remains a modern‐day complication for pediatric patients receiving treatment for extracranial solid tumors (ST), highlighting the need for reconsideration of our current approach toward PJP prophylaxis. This critical review aims to evaluate both universal and risk‐stratified approaches to PJP prophylaxis ...
Kriti Kumar, Denise M. Connolly, Ellen Kellington, Elyse Zelunka, Karla Kerrigan, Furqan Shaikh, Paul C. Nathan, Meredith S. Irwin, Sarah Cohen‐Gogo   +8 more
wiley   +1 more source

AML Disparities Across Racial Ancestry Groups: A Spotlight on the NPM1 Mutations. [PDF]

Int J Mol Sci
Sanaullah SA, Vidi PA, Pardee TS.
europepmc   +1 more source

Supplementary Data from Evaluation of Trends and Prognosis Over Time in Patients with AML Relapsing After Allogeneic Hematopoietic Cell Transplant Reveals Improved Survival for Young Patients in Recent Years

, 2023
Ali Bazarbachi, Christoph Schmid, Myriam Labopin, Dietrich W. Beelen, Igor Wolfgang Blau, Victoria Potter, Riitta Niittyvuopio, Gèrard Socié, Didier Blaise, Jaime Sanz, Fabio Ciceri, Iman Abou Dalle, Alexandros Spyridonidis, Gesine Bug, Jordi Esteve, Bipin N. Savani, Arnon Nagler, Mohamad Mohty   +17 more
openalex   +1 more source

Engineering Dosimetric Excellence In Total Body Irradiation: Tomotherapy‐Driven Protocols for Precision and Reproducibility

Precision Radiation Oncology, EarlyView.
• Objective: Assess helical Tomotherapy‐based TBI for clinical feasibility, dosimetric reproducibility, and in‐vivo accuracy using dual‐orientation simulation and patient‐specific QA. • Methodology: Implementation of ArcCHECK 3D diode array, ionization chamber verification, and in‐vivo dosimetry with OSLDs at 16 anatomical sites to ensure precise dose ...
Sandeep Singh, Dipesh, Supratik Sen, Abhay Kumar Singh, Mahipal, Manindra Bhushan, Jaskaran Singh Sethi, David K. Simson, Munish Gairola   +8 more
wiley   +1 more source

High TERF2 expression is associated with poor prognosis and its suppression attenuates progression in acute myeloid leukemia. [PDF]

Transl Cancer Res
Yao L, Wang X.
europepmc   +1 more source

Data from miR-196b–TLR7/8 Signaling Axis Regulates Innate Immune Signaling and Myeloid Maturation in <i>DNMT3A</i>-Mutant AML

, 2023
Holly A. Gamlen, Jennifer S. Romer-Seibert, Michael Lawler, Amanda M. Versace, Melanie L. Goetz, Yang Feng, Olga A. Guryanova, Neil Palmisiano, Sara E. Meyer   +8 more
openalex   +1 more source

AML [PDF]

, 2019
openaire   +1 more source

Semi‐mechanistic population PK/PD model to aid clinical understanding of myelodysplastic syndromes following treatment with Venetoclax and Azacitidine

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 448-459, March 2025.
Abstract Myelodysplastic syndromes (MDS) represent a group of bone marrow disorders involving cytopenias, hypercellular bone marrow, and dysplastic hematopoietic progenitors. MDS remains a challenge to treat due to the complex interplay between disease‐induced and treatment‐related cytopenias.
Neha Thakre, Corinna Maier, Jiuhong Zha, Benjamin Engelhardt, Johannes E. Wolff, Sven Mensing   +5 more
wiley   +1 more source